Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a predominant chronic liver condition globally, ...

Emerging opportunities in the STAT Inhibitors market lie in targeting dysregulated STAT pathways, particularly STAT3 and STAT5, for cancers and inflammatory conditions. Novel drugs like Tvardi's ...

Operator: Good afternoon, ladies and gentlemen, and welcome to the CytoSorbents Corp. Third Quarter 2025 Earnings Conference ...

Semax, a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro), derived from adrenocorticotropic hormone (ACTH), has emerged as a subject of growing interest in various scientific domains, ...

Cells have an internal skeleton that maintains their structure and also drives their movement. Known as the cytoskeleton, ...

Cytokinetics ( ($CYTK) ) just unveiled an announcement. On November 13, 2025, Cytokinetics announced the appointment of Jeffrey J. Hessekiel as ...

Researchers at the Kennedy Institute have provided the most comprehensive overview to date of how the distinctive segmented ...

Yale chemists have synthesized a complex, potentially cancer-fighting molecule found in sea sponges discovered off the coast of South Korea.

Third quarter 2025 revenue of $9.5 million, up 10% year-over-year Amended credit agreement with Avenue Capital Group which strengthens our balance sheet with ...